Target Portfolio and Progress Dashboard

The TREAT-AD centers are developing and disseminating tools that support target enabling packages (TEPs) for the experimental validation of novel, next generation therapeutic targets in AD. A TEP report may include a variety of TEP components to aid in chemical or biological probe development, for example antibody characterization reports, protein constructs and expression methods, crystal structures, high-throughput screening results, assay protocols, structure activity relationship studies and more. All available resources are linked and available in the AD Knowledge Portal.

Scroll right for all columns